India & United States — Food and Drug Administration
28 shared events · Importance 6 · Last updated Aug 03, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Tech
India: India>>> is the country where Zayn Malik>>> was discovered and developed, and where it first received regulatory approval from the India — Central Drugs Standard Control Organisation>>>.
United States — Food and Drug Administration: The United States — Food and Drug Administration>>> approved Zayn Malik>>> for use in the US, marking a significant regulatory milestone for Wockhardt>>> and opening access to the US market.
May 29, 2026 · 9 articles
Business
India: India>>> is the central focus of the event, with its pharmaceutical industry projected to double in size, becoming a global hub for generics, innovation, and manufacturing.
United States — Food and Drug Administration: The United States — Food and Drug Administration>>>'s approval of manufacturing plants in India>>> is a key indicator of the quality and trust in India>>>'s pharmaceutical sector.
Jun 08, 2026 · 8 articles
Business
India: India formulations sales grew 16% to Rs 5,475 crore, accounting for 36.1% of consolidated sales, and Sun Pharma maintained its position as the largest pharmaceutical company in India with market share rising to 8.5%.
United States — Food and Drug Administration: Sun Pharma filed three ANDAs and received approvals for six during the quarter, with 119 ANDAs awaiting FDA approval, reflecting ongoing regulatory engagement.
Jul 31, 2026 · 7 articles
Regulatory
India: India is a key location for Vivos' clinical trials and manufacturing expansion.
United States — Food and Drug Administration: The FDA approved Vivos' IDE application and reduced the safety follow-up period, facilitating the company's clinical development.
Jul 27, 2026 · 7 articles
Business
India: India is positioned as a growing economic power, a preferred global investment destination, and a significant player in global supply chains and the pharmaceutical sector, with strong growth projections and innovation initiatives.
United States — Food and Drug Administration: The United States — Food and Drug Administration is referenced as India hosts the largest number of its approved plants globally, underscoring the quality standards of India's pharmaceutical manufacturing.
Jun 09, 2026 · 8 articles
Regulatory
India: The manufacturing site in Pithampur, India, is the source of the recalled product, potentially affecting India's pharmaceutical export reputation.
United States — Food and Drug Administration: The FDA classified the recall as Class II and issued public notices, reinforcing its regulatory oversight role.
Jul 07, 2026 · 38 articles
Business
India: India will benefit from increased access to advanced multi-cancer detection screening, potentially improving public health outcomes by enabling earlier diagnosis and treatment of various cancers.
United States — Food and Drug Administration: The United States — Food and Drug Administration granted Breakthrough Device Designation to the Shield Multi-Cancer Detection test, recognizing its potential, though this does not imply regulatory approval or clearance.
Jul 03, 2026 · 6 articles
International
India: India's stock market is influenced by global and domestic factors, including inflation data and foreign investor activity.
United States — Food and Drug Administration: The United States — Food and Drug Administration is the regulatory body that Revolution Medicines will seek approval from for its experimental pancreatic cancer drug, daraxonrasib.
May 18, 2026 · 316 articles
Regulatory
India: India is the largest supplier of generic drugs to the US; the tariffs threaten its $9.7 billion pharma export market and could force strategic shifts.
United States — Food and Drug Administration: The FDA noted that generics constitute over 90% of US prescriptions, highlighting the policy's broad impact.
Jul 21, 2026 · 73 articles
International
India: Gor is also US Ambassador to India; India's regional interests are indirectly affected.
United States — Food and Drug Administration: Agreed to resume product testing in Bangladesh, supporting regulatory cooperation.
Aug 01, 2026 · 6 articles
Business
India: India is the home market and listing destination, with the IPO subject to Indian regulations and investor interest.
United States — Food and Drug Administration: The USFDA accreditation is a key regulatory approval for the company, enabling access to the US market.
Aug 03, 2026 · 6 articles
Business
India: India gains significant duty-free access for its exports to Oman, strengthening its economic footprint in the Middle East and diversifying its trade relations. This agreement is expected to boost India's merchandise and services exports, create job opportunities, and enhance its strategic position.
United States — Food and Drug Administration: Indian generic medicines approved by the United States — Food and Drug Administration>>> will receive fast-track marketing authorization in Oman>>> under the CEPA.
May 29, 2026 · 79 articles
Business
India: Lupin (company) and Natco Pharma, both headquartered in India, have expanded their global reach through this U.S. FDA approval.
United States — Food and Drug Administration: The United States — Food and Drug Administration granted approval for Eribulin Mesylate Injection, enabling Lupin (company) and Natco Pharma to market a generic alternative in the U.S.
Jun 03, 2026 · 8 articles
Tech
India: India is a potential market, with media coverage and potential patient impact.
United States — Food and Drug Administration: The FDA will review the trial data for potential approval. The companies plan to file for approval, and the vaccine could be available as soon as 2027 if approved.
Aug 19, 2026 · 108 articles
Business
India: The partnership strengthens India's pharmaceutical manufacturing capabilities, with both companies based in Hyderabad and the new facility in Visakhapatnam, contributing to the country's position as a global pharma hub.
United States — Food and Drug Administration: The new facility will be built to USFDA standards, ensuring regulatory compliance for the US market, which is critical for the partnership's success.
Aug 05, 2026 · 6 articles
Accidents
India: India, along with the African Union, postponed the India-Africa Forum Summit due to the evolving health situation in parts of Africa, demonstrating the international repercussions of the Ebola outbreak.
United States — Food and Drug Administration: The United States — Food and Drug Administration has approved Inmazeb, a combination of antibodies, to treat Zaire Ebolavirus infection, which Regeneron Pharmaceuticals has donated for potential use in the current outbreak.
May 18, 2026 · 505 articles
Regulatory
India: India is mentioned as the location of a Carl Zeiss Meditec research center, but it is not directly affected by this event.
United States — Food and Drug Administration: The FDA granted 510(k) clearance for ZEISS CLINIC 360, a regulatory action that enables the product's commercial launch in the U.S. This clearance is a routine but essential step for medical device software.
Aug 19, 2026 · 6 articles
Business
India: The partnership reinforces India's position as a global hub for biologics manufacturing, benefiting the country's pharmaceutical sector.
United States — Food and Drug Administration: OneSource's facilities are approved by the US FDA, which is a prerequisite for manufacturing biosimilars for the US market.
Jul 14, 2026 · 7 articles
Business
India: India is mentioned as the headquarters location of SS Innovations; no direct impact.
United States — Food and Drug Administration: FDA approval is a key objective for SS Innovations' SSi Mantra system; the appointment may support this goal.
Jul 14, 2026 · 6 articles
Business
India: Profound Medical's products are cleared in India.
United States — Food and Drug Administration: FDA has cleared TULSA-PRO and approved Sonalleve in the US.
Jul 16, 2026 · 7 articles
Regulatory
United States — Food and Drug Administration: The United States — Food and Drug Administration has issued an alert to Nigerians regarding the recall of Children's Ibuprofen Oral Suspension in the U.S. and is taking proactive measures to prevent its entry into the Nigerian market.
Jun 13, 2026 · 8 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how India and United States — Food and Drug Administration interact across events, view sentiment trends, and discover connected entities.
Open Dashboard